Patent details
EP2073834 Title: USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS
Basic Information
- Publication number:
- EP2073834
- PCT Application Number:
- PCT/US/2007/078226
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078423068
- PCT Publication Number:
- WO/2008/033888
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF LONG-LASTING FORMULATIONS OF GLP-1 PEPTIDES AS HYPOGLYCEMIC AGENTS
- French Title of Invention:
- UTILISATION DE FORMULATIONS À LONGUE DURÉE D'ACTION DE PEPTIDES GLP-1 COMEM AGENT HYPOGLYCÉMIANT
- German Title of Invention:
- VERWENDUNG VON LANGLEBIGER FORMULIERUNG VON GLP-1 PEPTIDE ALS HYPOGLYKÄMIE-MITTEL
- SPC Number:
Dates
- Filing date:
- 12/09/2007
- Grant date:
- 23/10/2013
- EP Publication Date:
- 23/10/2013
- PCT Publication Date:
- 20/03/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/07/2009
- EP B1 Publication Date:
- 23/10/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/09/2014
- Expiration date:
- 12/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/09/2007
- Name:
- GlaxoSmithKline LLC
- Address:
- One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)
Inventor
1
- Name:
- MATTHEWS Jessica, E.
- Address:
- United States (US)
2
- Name:
- BUSH Mark, A.
- Address:
- United States (US)
3
- Name:
- WALKER Susan, E.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 825472 P
- Priority Date:
- 13/09/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 868391 P
- Priority Date:
- 04/12/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 47/48;
| Filing date | Document type | Number of pages |
|---|